State Attorney General Anne Lopez has joined a coalition of 23 other attorneys general in an amicus brief calling on the U.S. Supreme Court to hear and reverse a lower court’s ruling that reimposes strict restrictions on how the medication abortion drug mifepristone can be prescribed and dispensed.
What You Need To Know
The brief was filed in support of petitions by the U.S. Food and Drug Administration and Danco Laboratories LLC to reverse a U.S. Court of Appeals for the Fifth Circuit’s ruling reinstating restrictions on the medication that have previously been eliminated
Mifepristone, in combination with misoprostol, is the only FDA-approved medication abortion drug
In the brief, the coalition states that the availability of mifepristone has proven critical in ‘improving abortion access, particularly in low-income, under-served, and rural communities, which experience higher rates of birth-related mortality and morbidity, and where non-medication abortion procedures (i.e., “procedural abortions”) may be unavailable.’
The coalition asked the high court to grant the petition to bring the case before the court and to reverse the Fifth Circuit decision
The brief was filed in support of petitions by the U.S. Food and Drug Administration and Danco Laboratories LLC to reverse a U.S. Court of Appeals for the Fifth Circuit’s ruling reinstating restrictions on the medication that have previously been eliminated.
